<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Adeno-associated virus,How to read a taxobox,Requests for expansion,Adenosine triphosphate,Adenovirus,American Society of Gene Therapy,Antibodies,Antibody-dependent cellular cytotoxicity,Atomic mass unit,Canavan disease,Cancer" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Adeno-associated virus - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Adeno-associated virus</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <table style="position:relative; margin: 0 0 0.5em 1em; border-collapse: collapse; float:right; background:white; clear:right; width:200px;" border="1" cellpadding="0">
<tr style="text-align:center;">
<th style="background: violet;"><span style="position:relative; float:right; font-size:70%;"><map name="ImageMap_12" id="ImageMap_12">
<area href="../../../h/o/w/Wikipedia%7EHow_to_read_a_taxobox_fa1e.html" shape="rect" coords="0,0,50,50" alt="Wikipedia:How to read a taxobox" title="Wikipedia:How to read a taxobox" /></map></span>
<div style="position: relative;"><span style="position:relative; float:right; font-size:70%;"><img src="../../../upload/shared/7/75/Information-silk.png" alt="How to read a taxobox" width="16" height="16" longdesc="../../../i/n/f/Image%7EInformation-silk.png_5dc8.html" usemap="#ImageMap_12" /></span></div>
<b>Adeno-associated virus</b></th>
</tr>
<tr style="text-align:center;">
<td></td>
</tr>
<tr style="text-align:center;">
<th style="background: violet;"><b><a href="../../../v/i/r/Virus_classification.html" title="Virus classification">Virus classification</a></b></th>
</tr>
<tr style="text-align:center;">
<td>
<table style="margin:0 auto; text-align:left; background:white;" cellpadding="2">
<tr valign="top">
<td>Group:</td>
<td>Group II <small>(<a href="../../../s/s/d/SsDNA_virus_1834.html" title="SsDNA virus">ssDNA</a>)</small></td>
</tr>
<tr valign="top">
<td>Family:</td>
<td><i><a href="../../../p/a/r/Parvoviridae.html" title="Parvoviridae">Parvoviridae</a></i><br /></td>
</tr>
<tr valign="top">
<td>Subfamily:</td>
<td><i>Parvovirinae</i><br /></td>
</tr>
<tr valign="top">
<td>Genus:</td>
<td><i>Dependovirus</i><br /></td>
</tr>
<tr valign="top">
<td>Species:</td>
<td><span style="white-space: nowrap"><i>adeno-associated virus</i></span><br /></td>
</tr>
</table>
</td>
</tr>
</table>
<p><b>Adeno-associated virus (AAV)</b> is the smallest of known human <a href="../../../v/i/r/Virus.html" title="Virus">viruses</a>. There is no <a href="../../../d/i/s/Disease.html" title="Disease">disease</a> which has been to date associated with AAV. The virus causes very mild <a href="../../../i/m/m/Immune_response.html" title="Immune response">immune response</a> and can infect non-dividing cells. It incorporates into the host cell's <a href="../../../g/e/n/Genome.html" title="Genome">genome</a>, but there is no evidence that it can cause <a href="../../../c/a/n/Cancer.html" title="Cancer">malignant transformation</a>. Because of these features it presents a very attractive subject for creating vectors for <a href="../../../g/e/n/Gene_therapy.html" title="Gene therapy">gene therapy</a>.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Overview"><span class="tocnumber">1</span> <span class="toctext">Overview</span></a></li>
<li class="toclevel-1"><a href="#Gene_Therapy_Vector"><span class="tocnumber">2</span> <span class="toctext">Gene Therapy Vector</span></a></li>
<li class="toclevel-1"><a href="#AAV_structure"><span class="tocnumber">3</span> <span class="toctext">AAV structure</span></a>
<ul>
<li class="toclevel-2"><a href="#AAV_genome.2C_transcriptome_and_proteome"><span class="tocnumber">3.1</span> <span class="toctext">AAV genome, transcriptome and proteome</span></a>
<ul>
<li class="toclevel-3"><a href="#ITR_sequences"><span class="tocnumber">3.1.1</span> <span class="toctext">ITR sequences</span></a></li>
<li class="toclevel-3"><a href="#rep_genes_and_Rep_proteins"><span class="tocnumber">3.1.2</span> <span class="toctext">rep genes and Rep proteins</span></a></li>
<li class="toclevel-3"><a href="#cap_genes_and_VP_proteins"><span class="tocnumber">3.1.3</span> <span class="toctext">cap genes and VP proteins</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1"><a href="#AAV_serotypes.2C_receptors_and_native_tropism"><span class="tocnumber">4</span> <span class="toctext">AAV serotypes, receptors and native tropism</span></a>
<ul>
<li class="toclevel-2"><a href="#Serotype_2"><span class="tocnumber">4.1</span> <span class="toctext">Serotype 2</span></a>
<ul>
<li class="toclevel-3"><a href="#Serotype_2_and_cancer"><span class="tocnumber">4.1.1</span> <span class="toctext">Serotype 2 and cancer</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Other_Serotypes"><span class="tocnumber">4.2</span> <span class="toctext">Other Serotypes</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#AAV_infection_cycle"><span class="tocnumber">5</span> <span class="toctext">AAV infection cycle</span></a></li>
<li class="toclevel-1"><a href="#Notes"><span class="tocnumber">6</span> <span class="toctext">Notes</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">7</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Overview" id="Overview"></a></p>
<h2><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: Overview">edit</a>]</span> <span class="mw-headline">Overview</span></h2>
<p><i><a href="../../../d/e/p/Dependovirus.html" title="Dependovirus">Dependovirus</a> adeno-associated virus</i> belongs to the <i><a href="../../../p/a/r/Parvoviridae.html" title="Parvoviridae">Parvoviridae</a></i>. The virus is a small (20 nm) replication-defective, <a href="../../../e/n/v/Enveloped_virus.html" title="Enveloped virus">nonenveloped virus</a> of <a href="../../../m/a/m/Mammals.html" title="Mammals">mammals</a> (including humans), which has not been associated with any known diseases. AAV is being extensively researched as a potential vector for <a href="../../../g/e/n/Gene_therapy.html" title="Gene therapy">gene therapy</a><sup id="_ref-GriegerSamulski2005_0" class="reference"><a href="#_note-GriegerSamulski2005" title="">[1]</a></sup> as it possesses many advantages in this regard.</p>
<p><a name="Gene_Therapy_Vector" id="Gene_Therapy_Vector"></a></p>
<h2><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: Gene Therapy Vector">edit</a>]</span> <span class="mw-headline">Gene Therapy Vector</span></h2>
<p>AAV advantages for gene therapy include: the lack of pathogenicity, the ability to infect non-dividing cells and the ability to stably integrate into the host cell genome at a specific site (designated AAVS1) in the human 19<sup>th</sup> <a href="../../../c/h/r/Chromosome.html" title="Chromosome">chromosome</a>.<sup id="_ref-SuroskyUrabe1997_0" class="reference"><a href="#_note-SuroskyUrabe1997" title="">[2]</a></sup> The last feature makes it superior to <a href="../../../r/e/t/Retrovirus.html" title="Retrovirus">retroviruses</a>, which present threat of a random insertion and of mutagenesis, which is sometimes followed by development of a <a href="../../../c/a/n/Cancer.html" title="Cancer">cancer</a>. The AAV genome integrates most frequently into the site mentioned, while random incorporations into the genome take place with a negligible frequency. AAVs also present very low <a href="../../../i/m/m/Immunogenicity.html" title="Immunogenicity">immunogenicity</a>, restricted only to generation of neutralizing <a href="../../../a/n/t/Antibodies.html" title="Antibodies">antibodies</a>, while they induce no <a href="../../../a/n/t/Antibody-dependent_cellular_cytotoxicity.html" title="Antibody-dependent cellular cytotoxicity">cytotoxic response</a>.<sup id="_ref-ChirmulePropert1999_0" class="reference"><a href="#_note-ChirmulePropert1999" title="">[3]</a></sup><sup id="_ref-HernandezWang1999_0" class="reference"><a href="#_note-HernandezWang1999" title="">[4]</a></sup><sup id="_ref-PonnazhaganMukherjee1997_0" class="reference"><a href="#_note-PonnazhaganMukherjee1997" title="">[5]</a></sup> This feature, along with the ability to infect quiescent cells present their dominance over <a href="../../../a/d/e/Adenovirus.html" title="Adenovirus">adenoviruses</a> as vectors for the human <a href="../../../g/e/n/Gene_therapy.html" title="Gene therapy">gene therapy</a>.</p>
<p>To date, AAV vectors have been used for first- and second-phase clinical trials for treatment of <a href="../../../c/y/s/Cystic_fibrosis.html" title="Cystic fibrosis">cystic fibrosis</a> and first-phase trials for <a href="../../../h/e/m/Hemophilia.html" title="Hemophilia">hemophilia</a>. Other trials have begun, concerning AAV safety for treatment of <a href="../../../c/a/n/Canavan_disease.html" title="Canavan disease">Canavan disease</a>, <a href="../../../m/u/s/Muscular_dystrophy.html" title="Muscular dystrophy">muscular dystrophy</a> and late infantile <a href="../../../n/e/u/Neuronal_ceroid_lipofuscinosis.html" title="Neuronal ceroid lipofuscinosis">neuronal ceroid lipofuscinosis</a>.</p>
<p><a name="AAV_structure" id="AAV_structure"></a></p>
<h2><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: AAV structure">edit</a>]</span> <span class="mw-headline">AAV structure</span></h2>
<div class="messagebox cleanup metadata plainlinks">
<table style="width:99%;background:none">
<tr>
<td width="60px"><a href="../../../w/i/k/Image%7EWiki_letter_w.svg_e974.html" class="image" title=""><img src="../../../upload/shared/thumb/6/6c/Wiki_letter_w.svg/45px-Wiki_letter_w.svg.png" alt="" width="45" height="45" longdesc="../../../w/i/k/Image%7EWiki_letter_w.svg_e974.html" /></a></td>
<td><b>Please help <a href="http://en.wikipedia.org../../../a/d/e/Adeno-associated_virus.html" class="external text" title="http://en.wikipedia.org../../../a/d/e/Adeno-associated_virus.html" rel="nofollow">improve this article</a> by expanding this section.</b><br />
<small>Further information might be found on the <a href="../../../a/d/e/Talk%7EAdeno-associated_virus_d556.html" title="Talk:Adeno-associated virus">talk page</a> or at <a href="../../../r/e/q/Wikipedia%7ERequests_for_expansion_6da0.html" title="Wikipedia:Requests for expansion">requests for expansion</a>. Please remove this message once the section has been expanded.<br />
This article has been tagged since <b>January 2007</b>.</small></td>
</tr>
</table>
</div>
<p><a name="AAV_genome.2C_transcriptome_and_proteome" id="AAV_genome.2C_transcriptome_and_proteome"></a></p>
<h3><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: AAV genome, transcriptome and proteome">edit</a>]</span> <span class="mw-headline">AAV genome, transcriptome and proteome</span></h3>
<p>The AAV genome is built of single-stranded deoxyribonucleic acid (ss<a href="../../../d/n/a/DNA_396c.html" title="DNA">DNA</a>), either positive- or negative-sensed, which is about 4.7 kilobase long. The genome comprises inverted terminal repeats (ITRs) at both ends of the DNA strand, and two <a href="../../../o/p/e/Open_reading_frame.html" title="Open reading frame">open reading frames</a> (ORFs): <i>rep</i> and <i>cap</i>. The former is composed of four overlapping genes encoding Rep proteins required for the AAV life cycle, and the latter contains overlapping nucleotide sequences of <a href="../../../c/a/p/Capsid.html" title="Capsid">capsid</a> proteins: VP1, VP2 and VP3, which interact together to form a capsid of an icosahedral symmetry.<sup id="_ref-Carter2000_0" class="reference"><a href="#_note-Carter2000" title="">[6]</a></sup></p>
<p><a name="ITR_sequences" id="ITR_sequences"></a></p>
<h4><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: ITR sequences">edit</a>]</span> <span class="mw-headline">ITR sequences</span></h4>
<p>The Inverted Terminal Repeat (ITR) sequences comprise 145 bases each. They were named so because of their symmetry, which was shown to be required for efficient multiplification of the AAV genome.<sup id="_ref-BohenzkyLefebvreBerns1988_0" class="reference"><a href="#_note-BohenzkyLefebvreBerns1988" title="">[7]</a></sup> Another property of these sequences is their ability to form a <a href="../../../h/a/i/Hairpin.html" title="Hairpin">hairpin</a>, which contributes to so-called self-priming that allows <a href="../../../p/r/i/Primase.html" title="Primase">primase</a>-independent synthesis of the second DNA strand. The ITRs were also shown to be required for both integration of the AAV DNA into the host cell genome (19<sup>th</sup> chromosome in humans) and rescue from it,<sup id="_ref-WangPonnazhagan1995_0" class="reference"><a href="#_note-WangPonnazhagan1995" title="">[8]</a></sup><sup id="_ref-WeitzmanKyostio1994_0" class="reference"><a href="#_note-WeitzmanKyostio1994" title="">[9]</a></sup> as well as for efficient encapsidation of the AAV DNA combined with generation of a fully-assembled, <a href="../../../d/e/o/Deoxyribonuclease.html" title="Deoxyribonuclease">deoxyribonuclease</a>-resistant AAV particles.<sup id="_ref-ZhouMuzyczka1998_0" class="reference"><a href="#_note-ZhouMuzyczka1998" title="">[10]</a></sup></p>
<p>With regard to gene therapy, ITRs seem to be the only sequences required <i><a href="../../../c/i/s/Cis-acting.html" title="Cis-acting">in cis</a></i> next to the therapeutic gene: structural (<i>cap</i>) and packaging (<i>rep</i>) genes can be delivered <i><a href="../../../t/r/a/Trans-acting_factors.html" title="Trans-acting factors">in trans</a></i>. With this assumption many methods were established for efficient production of recombinant AAV (rAAV) vectors containing a <a href="../../../r/e/p/Reporter_gene.html" title="Reporter gene">reporter</a> or therapeutic gene. However, it was also published that the ITRs are not the only elements required <i>in cis</i> for the effective replication and encapsidation. A few research groups have identified a sequence designated <i>cis-acting Rep-dependent element</i> (CARE) inside the coding sequence of the <i>rep</i> gene. CARE was shown to augment the replication and encapsidation when present <i>in cis</i>.<sup id="_ref-NonyTessier2001_0" class="reference"><a href="#_note-NonyTessier2001" title="">[11]</a></sup><sup id="_ref-0" class="reference"><a href="#_note-0" title="">[12]</a></sup><sup id="_ref-PhilpottGiraud2002_0" class="reference"><a href="#_note-PhilpottGiraud2002" title="">[13]</a></sup><sup id="_ref-1" class="reference"><a href="#_note-1" title="">[14]</a></sup></p>
<p><a name="rep_genes_and_Rep_proteins" id="rep_genes_and_Rep_proteins"></a></p>
<h4><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: rep genes and Rep proteins">edit</a>]</span> <span class="mw-headline"><i>rep</i> genes and Rep proteins</span></h4>
<p>On the "left side" of the genome there are two <a href="../../../p/r/o/Promoter.html" title="Promoter">promoters</a> called p5 and p19, from which two overlapping messenger ribonucleic acids (<a href="../../../m/r/n/MRNA_210c.html" title="MRNA">mRNAs</a>) of different length can be produced. Each of these contains an <a href="../../../i/n/t/Intron.html" title="Intron">intron</a> which can be either <a href="../../../s/p/l/Splicing_%28genetics%29.html" title="Splicing (genetics)">spliced</a> out or not. Given these possibilities, four various mRNAs, and consequently four various Rep proteins with overlapping sequence can be synthesized. Their names depict their sizes in <a href="../../../a/t/o/Atomic_mass_unit.html" title="Atomic mass unit">kilodaltons</a> (kDa): Rep78, Rep68, Rep52 and Rep40.<sup id="_ref-KyostioOwens1994_0" class="reference"><a href="#_note-KyostioOwens1994" title="">[15]</a></sup> Rep78 and 68 can specifically bind the <a href="../../../h/a/i/Hairpin.html" title="Hairpin">hairpin</a> formed by the ITR in the self-priming act and cleave at a specific region, designated terminal resolution site, within the hairpin. They were also showed necessary for the AAVS1-specific integration of the AAV genome. All four Rep proteins were shown to bind <a href="../../../a/d/e/Adenosine_triphosphate.html" title="Adenosine triphosphate">ATP</a> and to possess <a href="../../../h/e/l/Helicase.html" title="Helicase">helicase</a> activity. It was also shown that they upregulate the transcription from the p40 promoter (mentioned below), but downregulate both p5 and p19 promoters.<sup id="_ref-ImMuzyczka1990_0" class="reference"><a href="#_note-ImMuzyczka1990" title="">[16]</a></sup><sup id="_ref-ImMuzyczka1992_0" class="reference"><a href="#_note-ImMuzyczka1992" title="">[17]</a></sup><sup id="_ref-KyostioOwens1994_1" class="reference"><a href="#_note-KyostioOwens1994" title="">[15]</a></sup><sup id="_ref-Samulski2003_0" class="reference"><a href="#_note-Samulski2003" title="">[18]</a></sup><sup id="_ref-TrempeCarter1988a_0" class="reference"><a href="#_note-TrempeCarter1988a" title="">[19]</a></sup><sup id="_ref-WeitzmanKyostio1994_1" class="reference"><a href="#_note-WeitzmanKyostio1994" title="">[9]</a></sup></p>
<p><a name="cap_genes_and_VP_proteins" id="cap_genes_and_VP_proteins"></a></p>
<h4><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: cap genes and VP proteins">edit</a>]</span> <span class="mw-headline"><i>cap</i> genes and VP proteins</span></h4>
<p>The right side of a positive-sensed AAV genome encodes overlapping sequences of three capsid proteins, VP1, VP2 and VP3, which start from one promoter, designated p40. The molecular weights of these proteins are 87, 72 and 62 kiloDaltons, respectively.<sup id="_ref-JayLaughlin1981_0" class="reference"><a href="#_note-JayLaughlin1981" title="">[20]</a></sup> All three of them are translated from one mRNA. After this mRNA is synthesized, it can be <a href="../../../s/p/l/Splicing_%28genetics%29.html" title="Splicing (genetics)">spliced</a> in two different manners: either longer or shorter <a href="../../../i/n/t/Intron.html" title="Intron">intron</a> can be excised, which results in formation of two pools of mRNAs: 2.3 kb-, and 2.6 kb-long. Usually, especially in the presence of <a href="../../../a/d/e/Adenovirus.html" title="Adenovirus">adenovirus</a>, the longer intron is preferred, so the 2.3-kb-long mRNA represents so-called major splice. In this form the first <a href="../../../s/t/a/Start_codon.html" title="Start codon">AUG codon</a>, from which the synthesis of VP1 protein starts, is cut out, resulting in a reduced overall level of VP1 protein synthesis. The first AUG codon, which remains in the major splice, is the initiation codon for VP3 protein. However, upstream of that codon in the same open reading frame lies the ACG sequence, which endcodes threonine, but is surrounded by the optimal <a href="../../../k/o/z/Kozak_consensus_sequence.html" title="Kozak consensus sequence">Kozak context</a>, that contributes to a low level of synthesis of VP2 protein, which is actually VP3 protein with additional N terminal residues, as is VP1.<sup id="_ref-BecerraRose1985_0" class="reference"><a href="#_note-BecerraRose1985" title="">[21]</a></sup><sup id="_ref-CassinottiWeitz1988_0" class="reference"><a href="#_note-CassinottiWeitz1988" title="">[22]</a></sup><sup id="_ref-MuralidharBecerra1994_0" class="reference"><a href="#_note-MuralidharBecerra1994" title="">[23]</a></sup><sup id="_ref-TrempeCarter1988b_0" class="reference"><a href="#_note-TrempeCarter1988b" title="">[24]</a></sup></p>
<p>Since the bigger intron is preferred to be spliced out, and since in the major splice the ACG codon is a much weaker <a href="../../../t/r/a/Translation.html" title="Translation">translation</a> initiation signal, the ratio at which the AAV structural proteins are synthesized <i>in vivo</i> is about 1:1:20, which is the same as in the mature virus particle.<sup id="_ref-RabinowitzSamulski2000_0" class="reference"><a href="#_note-RabinowitzSamulski2000" title="">[25]</a></sup> The unique fragment at the N terminus of VP1 protein was shown to possess the <a href="../../../p/h/o/Phospholipase.html" title="Phospholipase">phospholipase</a> A2 (PLA2) activity, which is probably required for the releasing of AAV particles from late <a href="../../../e/n/d/Endosome.html" title="Endosome">endosomes</a>.<sup id="_ref-GirodWobus2002_0" class="reference"><a href="#_note-GirodWobus2002" title="">[26]</a></sup> Muralidhar <i>et. al.</i> reported that VP2 and VP3 are crucial for correct virion assembly.<sup id="_ref-MuralidharBecerra1994_1" class="reference"><a href="#_note-MuralidharBecerra1994" title="">[23]</a></sup> More recently, however, Warrington <i>et al</i> showed VP2 to be unnecessary for the complete virus particle formation and an efficient infectivity, and also presented that VP2 can tolerate large insertions in its N terminus, while VP1 can not, probably because of the PLA2 domain presence.<sup id="_ref-WarringtonGorbatyuk1994_0" class="reference"><a href="#_note-WarringtonGorbatyuk1994" title="">[27]</a></sup></p>
<p>The <a href="../../../c/r/y/Crystal_structure.html" title="Crystal structure">crystal structure</a> of the VP3 protein was determined by Xie, Bue, <i>et al</i>.<sup id="_ref-XieBu2002_0" class="reference"><a href="#_note-XieBu2002" title="">[28]</a></sup></p>
<p><a name="AAV_serotypes.2C_receptors_and_native_tropism" id="AAV_serotypes.2C_receptors_and_native_tropism"></a></p>
<h2><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: AAV serotypes, receptors and native tropism">edit</a>]</span> <span class="mw-headline">AAV serotypes, receptors and native tropism</span></h2>
<p>As of 2006 there have been 11 AAV <a href="../../../s/e/r/Serotype.html" title="Serotype">serotypes</a> described, the 11<sup>th</sup> in 2004.<sup id="_ref-MoriWang2004_0" class="reference"><a href="#_note-MoriWang2004" title="">[29]</a></sup> All of the known serotypes can infect cells from multiple diverse tissue types. Tissue specificity is determined by the capsid serotype and pseudotyping of AAV vectors to alter their tropism range will likely be important to their use in therapy.</p>
<p><a name="Serotype_2" id="Serotype_2"></a></p>
<h3><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: Serotype 2">edit</a>]</span> <span class="mw-headline">Serotype 2</span></h3>
<p>Serotype 2 (AAV2) has been the most extensively examined so far.<sup id="_ref-BartlettSamulski1998_0" class="reference"><a href="#_note-BartlettSamulski1998" title="">[30]</a></sup><sup id="_ref-FischerBeck2003_0" class="reference"><a href="#_note-FischerBeck2003" title="">[31]</a></sup><sup id="_ref-NicklinBuening2001_0" class="reference"><a href="#_note-NicklinBuening2001" title="">[32]</a></sup><sup id="_ref-RabinowitzXiao1999_0" class="reference"><a href="#_note-RabinowitzXiao1999" title="">[33]</a></sup><sup id="_ref-ShiBartlett2003_0" class="reference"><a href="#_note-ShiBartlett2003" title="">[34]</a></sup><sup id="_ref-WuXiao2000_0" class="reference"><a href="#_note-WuXiao2000" title="">[35]</a></sup> AAV2 presents natural tropism towards e.g. <a href="../../../s/k/e/Skeletal_muscle.html" title="Skeletal muscle">skeletal muscles</a>,<sup id="_ref-MannoChew2003_0" class="reference"><a href="#_note-MannoChew2003" title="">[36]</a></sup> <a href="../../../n/e/u/Neuron.html" title="Neuron">neurons</a>,<sup id="_ref-BartlettSamulski1998_1" class="reference"><a href="#_note-BartlettSamulski1998" title="">[30]</a></sup> <a href="../../../v/a/s/Vascular_smooth_muscle.html" title="Vascular smooth muscle">vascular smooth muscle</a> cells<sup id="_ref-RichterIwata2000_0" class="reference"><a href="#_note-RichterIwata2000" title="">[37]</a></sup> and <a href="../../../h/e/p/Hepatocyte.html" title="Hepatocyte">hepatocytes</a>.<sup id="_ref-KoeberlAlexander1997_0" class="reference"><a href="#_note-KoeberlAlexander1997" title="">[38]</a></sup></p>
<p>Three cell receptors haver been described for AAV2: <a href="../../../h/e/p/Heparan_sulfate.html#Proteoglycans" title="Heparan sulfate">heparan sulfate proteoglican</a> (HSPG), a<sub>V</sub>ÃŸ<sub>5</sub> <a href="../../../i/n/t/Integrin.html" title="Integrin">integrin</a> and <a href="../../../f/i/b/Fibroblast_growth_factor.html" title="Fibroblast growth factor">fibroblast growth factor</a> receptor 1 (FGFR-1). The first functions as a primary receptor, while the latter two have a co-receptor activity and enable AAV to enter the cell by receptor-mediated <a href="../../../e/n/d/Endocytosis.html" title="Endocytosis">endocytosis</a>.<sup id="_ref-QinqMah1999_0" class="reference"><a href="#_note-QinqMah1999" title="">[39]</a></sup><sup id="_ref-SummerfordSamulski1998_0" class="reference"><a href="#_note-SummerfordSamulski1998" title="">[40]</a></sup><sup id="_ref-SummerfordBartlett1999_0" class="reference"><a href="#_note-SummerfordBartlett1999" title="">[41]</a></sup>) These study results have been disputed by Qiu, Handa, <i>et al</i>.<sup id="_ref-QiuHanda2001_0" class="reference"><a href="#_note-QiuHanda2001" title="">[42]</a></sup> HSPG functions as the primary receptor, though its abundance in the <a href="../../../e/x/t/Extracellular_matrix.html" title="Extracellular matrix">extracellular matrix</a> can scavenge AAV particles and impair the infection efficiency.<sup id="_ref-PajusolaGruchala2002_0" class="reference"><a href="#_note-PajusolaGruchala2002" title="">[43]</a></sup></p>
<p><a name="Serotype_2_and_cancer" id="Serotype_2_and_cancer"></a></p>
<h4><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: Serotype 2 and cancer">edit</a>]</span> <span class="mw-headline">Serotype 2 and cancer</span></h4>
<p>Studies have shown that serotype 2 of the virus (AAV-2) apparently kills cancer cells without harming healthy ones. "Our results suggest that adeno-associated virus type 2, which infects the majority of the population but has no known ill effects, kills multiple types of cancer cells yet has no effect on healthy cells," said <a href="http://www.fred.psu.edu/ds/retrieve/fred/investigator/cmm10" class="external text" title="http://www.fred.psu.edu/ds/retrieve/fred/investigator/cmm10" rel="nofollow">Craig Meyers</a>, a professor of <a href="../../../i/m/m/Immunology.html" title="Immunology">immunology</a> and <a href="../../../m/i/c/Microbiology.html" title="Microbiology">microbiology</a> at the <a href="../../../p/e/n/Penn_State_a5b4.html" title="Penn State">Penn State</a> College of Medicine in <a href="../../../p/e/n/Pennsylvania.html" title="Pennsylvania">Pennsylvania</a>.<sup id="_ref-Cnn2005_0" class="reference"><a href="#_note-Cnn2005" title="">[44]</a></sup> This could lead to a new anti-cancer agent.</p>
<p><a name="Other_Serotypes" id="Other_Serotypes"></a></p>
<h3><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: Other Serotypes">edit</a>]</span> <span class="mw-headline">Other Serotypes</span></h3>
<p>Although AAV2 is the most popular serotype in various AAV-based research, it has been shown that other serotypes can be more effective as gene delivery vectors. For instance AAV6 appears much better in infecting airway epithelial cells, AAV7 presents very high transduction rate of murine skeletal muscle cells (similarly to AAV1 and AAV5), AAV8 is superb in transducing hepatocytes<sup id="_ref-GaoAlvira2002_0" class="reference"><a href="#_note-GaoAlvira2002" title="">[45]</a></sup><sup id="_ref-HalbertAllen2001_0" class="reference"><a href="#_note-HalbertAllen2001" title="">[46]</a></sup><sup id="_ref-RabinowitzBowles2004_0" class="reference"><a href="#_note-RabinowitzBowles2004" title="">[47]</a></sup> and AAV1 and 5 were shown to be very efficient in gene delivery to vascular endothelial cells.<sup id="_ref-ChenKapturczak2005_0" class="reference"><a href="#_note-ChenKapturczak2005" title="">[48]</a></sup> AAV6, a hybrid of AAV1 and AAV2,<sup id="_ref-RabinowitzBowles2004_1" class="reference"><a href="#_note-RabinowitzBowles2004" title="">[47]</a></sup> also shows lower immunogenicity than AAV2.<sup id="_ref-HalbertAllen2001_1" class="reference"><a href="#_note-HalbertAllen2001" title="">[46]</a></sup></p>
<p>Serotypes can differ with the respect to the receptors they are bound to. For example AAV4 and AAV5 transduction can be inhibited by soluble <a href="../../../s/i/a/Sialic_acid.html" title="Sialic acid">sialic acids</a> (of different form for each of these serotypes),<sup id="_ref-KaludovBrown2001_0" class="reference"><a href="#_note-KaludovBrown2001" title="">[49]</a></sup> and AAV5 was shown to enter cells via the <a href="../../../p/l/a/Platelet-derived_growth_factor.html" title="Platelet-derived growth factor">platelet-derived growth factor</a> receptor.<sup id="_ref-DiPasqualeDavidson2003_0" class="reference"><a href="#_note-DiPasqualeDavidson2003" title="">[50]</a></sup></p>
<p><a name="AAV_infection_cycle" id="AAV_infection_cycle"></a></p>
<h2><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: AAV infection cycle">edit</a>]</span> <span class="mw-headline">AAV infection cycle</span></h2>
<p>There are several steps in the AAV infection cycle, from infecting a cell to producing new infectious particles:</p>
<ol>
<li>attachment to the <a href="../../../c/e/l/Cell_membrane.html" title="Cell membrane">cell membrane</a></li>
<li><a href="../../../e/n/d/Endocytosis.html" title="Endocytosis">endocytosis</a></li>
<li>endosomal trafficking</li>
<li>escape from the late <a href="../../../e/n/d/Endosome.html" title="Endosome">endosome</a> or <a href="../../../l/y/s/Lysosome.html" title="Lysosome">lysosome</a></li>
<li>translocation to the <a href="../../../c/e/l/Cell_nucleus.html" title="Cell nucleus">nucleus</a></li>
<li>formation of double-stranded DNA replicative form of the AAV genome</li>
<li><i>rep</i> genes expression</li>
<li>genome <a href="../../../d/n/a/DNA_replication_3f4b.html" title="DNA replication">replication</a></li>
<li><i>cap</i> genes expression, synthesis of progeny ssDNA particles</li>
<li>assembly of complete <a href="../../../v/i/r/Virion.html" title="Virion">virions</a>, and</li>
<li>release from the infected cell.</li>
</ol>
<p>Some of these steps may look different in various types of cells, which, in part, contributes to the defined and quite limited native tropism of AAV. Replication of the virus can also vary in one cell type, depending on the cell's current <a href="../../../c/e/l/Cell_cycle.html" title="Cell cycle">cell cycle</a> phase.<sup id="_ref-RohrKronenwett2002_0" class="reference"><a href="#_note-RohrKronenwett2002" title="">[51]</a></sup></p>
<p>The characteristic feature of the adeno-associated virus is a deficiency in replication and thus its inability to multiply in unaffected cells. The first factor that was described as providing successful generation of new AAV particles, was the <a href="../../../a/d/e/Adenovirus.html" title="Adenovirus">adenovirus</a>, from which the AAV name originated. It was then shown that AAV replication can be facilitated by selected proteins derived from the adenovirus genome,<sup id="_ref-MatsushitaElliger1998_0" class="reference"><a href="#_note-MatsushitaElliger1998" title="">[52]</a></sup><sup id="_ref-MyersLaughlin1980_0" class="reference"><a href="#_note-MyersLaughlin1980" title="">[53]</a></sup> by other viruses such as HSV,<sup id="_ref-HandaCarter1979_0" class="reference"><a href="#_note-HandaCarter1979" title="">[54]</a></sup> or by genotoxic agents, such as <a href="../../../u/v/_/UV_deaa.html" title="UV">UV</a> irradiation or <a href="../../../h/y/d/Hydroxyurea.html" title="Hydroxyurea">hydroxyurea</a>.<sup id="_ref-YalkinogluHeilbronn1988_0" class="reference"><a href="#_note-YalkinogluHeilbronn1988" title="">[55]</a></sup><sup id="_ref-YakobsonKoch1987_0" class="reference"><a href="#_note-YakobsonKoch1987" title="">[56]</a></sup><sup id="_ref-YakobsonHrynko1989_0" class="reference"><a href="#_note-YakobsonHrynko1989" title="">[57]</a></sup></p>
<p>The minimal set of the adenoviral genes required for efficient generation of progeny AAV particles, was discovered by Matsushita, Ellinger <i>et al</i>.<sup id="_ref-MatsushitaElliger1998_1" class="reference"><a href="#_note-MatsushitaElliger1998" title="">[52]</a></sup> This discovery allowed for new production methods of recombinant AAV, which do not require adenoviral co-infection of the AAV-producing cells. In the absence of helper virus or genotoxic factors, AAV DNA can either integrate into the host genome or persist in <a href="../../../e/p/i/Episome.html" title="Episome">episomal</a> form. In the former case integration is mediated by Rep78 and Rep68 proteins and requires the presence of ITRs flanking the region being integrated. In mice, the AAV genome has been observed persisting for long periods of time in quiescent tissues, such as skeletal muscles, in episomal form (a circular head-to-tail conformation).<sup id="_ref-DuanSharma1998_0" class="reference"><a href="#_note-DuanSharma1998" title="">[58]</a></sup></p>
<p><a name="Notes" id="Notes"></a></p>
<h2><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: Notes">edit</a>]</span> <span class="mw-headline">Notes</span></h2>
<div class="references-2column">
<ol class="references">
<li id="_note-GriegerSamulski2005"><b><a href="#_ref-GriegerSamulski2005_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFGriegerSamulski2005">Grieger, JC &amp; RJ Samulski (2005), "Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.", <i>Advances in biochemical engineering/biotechnology</i> (no. 99): 119-145</cite></li>
<li id="_note-SuroskyUrabe1997"><b><a href="#_ref-SuroskyUrabe1997_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFSuroskyUrabeGodwin1997">Surosky, RT; M Urabe &amp; SG <i>et al</i> Godwin (1997), "Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome", <i>Journal of virology</i> 71(10), <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9311886" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9311886">PMID 9311886</a></cite></li>
<li id="_note-ChirmulePropert1999"><b><a href="#_ref-ChirmulePropert1999_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFChirmulePropertMagosin1999">Chirmule, N; K Propert &amp; S <i>et al</i> Magosin (1999), "Immune responses to adenovirus and adeno-associated virus in humans", <i>Gene therapy</i> (no. September): 1574-83, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10490767" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10490767">PMID 10490767</a></cite></li>
<li id="_note-HernandezWang1999"><b><a href="#_ref-HernandezWang1999_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFHernandezWangKearns1999">Hernandez, YJ; J Wang &amp; WG <i>et al</i> Kearns (1999), "Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model", <i>Journal of virology</i> (no. October): 8549-58, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10482608" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10482608">PMID 10482608</a></cite></li>
<li id="_note-PonnazhaganMukherjee1997"><b><a href="#_ref-PonnazhaganMukherjee1997_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFPonnazhaganMukherjeeYoder1997">Ponnazhagan, S; P Mukherjee &amp; MC <i>et al</i> Yoder (1997), "Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice", <i>Gene</i> (no. Apr 29): 203-10, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9185868" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9185868">PMID 9185868</a></cite></li>
<li id="_note-Carter2000"><b><a href="#_ref-Carter2000_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFCarter2000">Carter, BJ (2000), "Adeno-associated virus and adeno-associated virus vectors for gene delivery", in DD Lassic &amp; N Smyth Templeton, <i>Gene Therapy: Therapeutic Mechanisms and Strategies</i>, <a href="../../../n/e/w/New_York_City_1428.html" title="New York City">New York City</a>: Marcel Dekker, Inc., <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-585-39515-2</a></cite></li>
<li id="_note-BohenzkyLefebvreBerns1988"><b><a href="#_ref-BohenzkyLefebvreBerns1988_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFBohenzkyLeFebvreBerns1988">Bohenzky, RA; RB LeFebvre &amp; KI Berns (1988), "Sequence and symmetry requirements within the internal palindromic sequences of the adeno-associated virus terminal repeat", <i>Virology</i> 166(2), <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2845646" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2845646">PMID 2845646</a></cite></li>
<li id="_note-WangPonnazhagan1995"><b><a href="#_ref-WangPonnazhagan1995_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFWangPonnazhaganSrivastava1995">Wang, X.S.; S. Ponnazhagan &amp; A Srivastava (1995), "Rescue and replication signals of the adeno-associated virus 2 genome", <i>Journal of Molecular Biology</i> 250(5): 573-80, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7623375" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7623375">PMID 7623375</a></cite></li>
<li id="_note-WeitzmanKyostio1994">^ <a href="#_ref-WeitzmanKyostio1994_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-WeitzmanKyostio1994_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" id="CITEREFWeitzmanKyostioKotinOwens1994">Weitzman, MD; SR Kyostio &amp; RM Kotin et al. (1994), "Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA", <i>Proceedings of the National Academy of Sciences of the United States of America</i> 91(13): 5808-12, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8016070" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8016070">PMID 8016070</a></cite></li>
<li id="_note-ZhouMuzyczka1998"><b><a href="#_ref-ZhouMuzyczka1998_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFZhouMuzyczka1998">Zhou, X &amp; N Muzyczka (1998), "In vitro packaging of adeno-associated virus DNA", <i>Journal of virology</i> 72(4): 3241-7, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9525651" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9525651">PMID 9525651</a></cite></li>
<li id="_note-NonyTessier2001"><b><a href="#_ref-NonyTessier2001_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFNonyTessierChadeufWard2001">Nony, P; J Tessier &amp; G Chadeuf et al. (2001), "Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences", <i>Journal of virology</i> 75(20): 9991-4, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11559833" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11559833">PMID 11559833</a></cite></li>
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFNonyChadeufTessierMoullier2003">Nony, P; G Chadeuf &amp; J Tessier et al. (2003), "Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles", <i>Journal of virology</i> 77(1), <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12477885" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12477885">PMID 12477885</a></cite></li>
<li id="_note-PhilpottGiraud2002"><b><a href="#_ref-PhilpottGiraud2002_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFPhilpottGiraud-WaliDupuisGomos2002">Philpott, NJ; C Giraud-Wali &amp; C Dupuis et al. (2002), "Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis", <i>Journal of virology</i> 76(11), <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11991970" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11991970">PMID 11991970</a></cite></li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <cite style="font-style:normal" id="CITEREFTullisShenk2000">Tullis, GE &amp; T Shenk (2000), "Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size", <i>Journal of virology</i> 74(24), <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11090148" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11090148">PMID 11090148</a></cite></li>
<li id="_note-KyostioOwens1994">^ <a href="#_ref-KyostioOwens1994_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-KyostioOwens1994_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" id="CITEREFKyostioOwensWeitzmanAntoni1994">Kyostio, SR; RA Owens &amp; MD Weitzman et al. (1994), "Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels", <i>Journal of virology</i> 68(5): 2947-57, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8151765" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8151765">PMID 8151765</a></cite></li>
<li id="_note-ImMuzyczka1990"><b><a href="#_ref-ImMuzyczka1990_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFImMuzyczka1990">Im, DS &amp; N Muzyczka (1990), "The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity.", <i>Cell</i> 61(3): 447-57, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2159383" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2159383">PMID 2159383</a></cite></li>
<li id="_note-ImMuzyczka1992"><b><a href="#_ref-ImMuzyczka1992_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFImMuzyczka1992">Im, DS &amp; N Muzyczka (1992), "Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization", <i>Journal of virology</i> 66(2): 1119-28, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1309894" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1309894">PMID 1309894</a></cite></li>
<li id="_note-Samulski2003"><b><a href="#_ref-Samulski2003_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFSamulski2003">Samulski, RJ (2003), "AAV vectors, the future workhorse of human gene therapy", <i>Ernst Schering Research Foundation workshop</i> (no. 43): 25-40, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12894449" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12894449">PMID 12894449</a></cite></li>
<li id="_note-TrempeCarter1988a"><b><a href="#_ref-TrempeCarter1988a_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFTrempeCarter1988a">Trempe, JP &amp; BJ Carter (1988a), "Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation", <i>Journal of virology</i> (no. 1): 68-74, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2824856" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2824856">PMID 2824856</a></cite></li>
<li id="_note-JayLaughlin1981"><b><a href="#_ref-JayLaughlin1981_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFJayLaughlinCarter1981">Jay, FT; CA Laughlin &amp; BJ Carter (1981), "Eukaryotic translational control: adeno-associated virus protein synthesis is affected by a mutation in the adenovirus DNA-binding protein", <i>Proceedings of the National Academy of Sciences of the United States of America</i> 78(5): 2927-31, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=6265925" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=6265925">PMID 6265925</a></cite></li>
<li id="_note-BecerraRose1985"><b><a href="#_ref-BecerraRose1985_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFBecerraRoseHardyother1985">Becerra, SP; JA Rose &amp; M Hardy et al. (1985), "Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon", <i>Proceedings of the National Academy of Sciences of the United States of America</i> 82(23): 7919-23, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2999784" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2999784">PMID 2999784</a></cite></li>
<li id="_note-CassinottiWeitz1988"><b><a href="#_ref-CassinottiWeitz1988_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFCassinottiWeitzTratschin1988">Cassinotti, P; M Weitz &amp; JD Tratschin (1988), "Organization of the adeno-associated virus (AAV) capsid gene: mapping of a minor spliced mRNA coding for virus capsid protein 1", <i>Virology</i> 167(1): 176-84, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2847413" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2847413">PMID 2847413</a></cite></li>
<li id="_note-MuralidharBecerra1994">^ <a href="#_ref-MuralidharBecerra1994_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-MuralidharBecerra1994_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" id="CITEREFMuralidharBecerraRose1994">Muralidhar, S; SP Becerra &amp; JA Rose (1994), "Site-directed mutagenesis of adeno-associated virus type 2 structural protein initiation codons: effects on regulation of synthesis and biological activity", <i>Journal of virology</i> 68(1): 170-6, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8254726" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8254726">PMID 8254726</a></cite></li>
<li id="_note-TrempeCarter1988b"><b><a href="#_ref-TrempeCarter1988b_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFTrempeCarter1988b">Trempe, JP &amp; BJ Carter (1988b), "Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein", <i>Journal of virology</i> 62(9): 3356-63, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2841488" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2841488">PMID 2841488</a></cite></li>
<li id="_note-RabinowitzSamulski2000"><b><a href="#_ref-RabinowitzSamulski2000_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFRabinowitzSamulski2000">Rabinowitz, JE &amp; RJ Samulski (2000), "Building a better vector: the manipulation of AAV virions", <i>Virology</i> 278(2): 301-8, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11118354" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11118354">PMID 11118354</a></cite></li>
<li id="_note-GirodWobus2002"><b><a href="#_ref-GirodWobus2002_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFGirodWobusZ.C3.A1doriothers2002">Girod, A; CE Wobus &amp; Z ZÃ¡dori et al. (2002), "The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity", <i>The Journal of general virology</i> 83(5): 973-8, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11961250" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11961250">PMID 11961250</a></cite></li>
<li id="_note-WarringtonGorbatyuk1994"><b><a href="#_ref-WarringtonGorbatyuk1994_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFWarringtonGorbatyukHarrisonothers2004">Warrington, KH,Jr; OS Gorbatyuk &amp; JK Harrison et al. (2004), "Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus", <i>Journal of virology</i> 78(12): 6595-609, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15163751" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15163751">PMID 15163751</a></cite></li>
<li id="_note-XieBu2002"><b><a href="#_ref-XieBu2002_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFXieBuBhatiaothers2002">Xie, Q; W Bu &amp; S Bhatia et al. (2002), "The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy", <i>Proceedings of the National Academy of Sciences of the United States of America</i> 99(16): 10405-10, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12136130" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12136130">PMID 12136130</a></cite></li>
<li id="_note-MoriWang2004"><b><a href="#_ref-MoriWang2004_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFMoriWangTakeuchiKanda2004">Mori, S; L Wang &amp; T Takeuchi et al. (2004), "Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein", <i>Virology</i> 330(2): 375-83, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15567432" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15567432">PMID 15567432</a></cite></li>
<li id="_note-BartlettSamulski1998">^ <a href="#_ref-BartlettSamulski1998_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-BartlettSamulski1998_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" id="CITEREFBartlettSamulskiMcCownothers1998">Bartlett, JS; RJ Samulski &amp; TJ McCown et al. (1998), "Selective and rapid uptake of adeno-associated virus type 2 in brain", <i>Human gene therapy</i> 9(8): 1181-6, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9625257" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9625257">PMID 9625257</a></cite></li>
<li id="_note-FischerBeck2003"><b><a href="#_ref-FischerBeck2003_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFFischerBeckSmithothers2003">Fischer, AC; SE Beck &amp; CI Smith et al. (2003), "Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques", <i>Molecular therapy&#160;: the journal of the <a href="../../../a/m/e/American_Society_of_Gene_Therapy_f15f.html" title="American Society of Gene Therapy">American Society of Gene Therapy</a></i> 8(6): 918-26, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14664794" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14664794">PMID 14664794</a></cite></li>
<li id="_note-NicklinBuening2001"><b><a href="#_ref-NicklinBuening2001_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFNicklinBueningDishartothers2001">Nicklin, SA; H Buening &amp; KL Dishart et al. (2001), "Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells", <i>Molecular therapy&#160;: the journal of the American Society of Gene Therapy</i> 4(3): 174-81, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11545607" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11545607">PMID 11545607</a></cite></li>
<li id="_note-RabinowitzXiao1999"><b><a href="#_ref-RabinowitzXiao1999_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFRabinowitzXiaoSamulski1999">Rabinowitz, JE; W Xiao &amp; RJ Samulski (1999), "Insertional mutagenesis of AAV2 capsid and the production of recombinant virus", <i>Virology</i> 265(2): 274-85, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10600599" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10600599">PMID 10600599</a></cite></li>
<li id="_note-ShiBartlett2003"><b><a href="#_ref-ShiBartlett2003_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFShiBartlett2003">Shi, W &amp; JS Bartlett (2003), "RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism", <i>Molecular therapy&#160;: the journal of the American Society of Gene Therapy</i> 7(4): 515-25, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12727115" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12727115">PMID 12727115</a></cite></li>
<li id="_note-WuXiao2000"><b><a href="#_ref-WuXiao2000_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFWuXiaoConlonothers2000">Wu, P; W Xiao &amp; T Conlon et al. (2000), "Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism", <i>Journal of virology</i> 74(18): 8635-47, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10954565" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10954565">PMID 10954565</a></cite></li>
<li id="_note-MannoChew2003"><b><a href="#_ref-MannoChew2003_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFMannoChewHutchisonothers2003">Manno, CS; AJ Chew &amp; S Hutchison et al. (2003), "AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B", <i>Blood</i> 101(8): 2963-72, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12515715" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12515715">PMID 12515715</a></cite></li>
<li id="_note-RichterIwata2000"><b><a href="#_ref-RichterIwata2000_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFRichterIwataNyhuisothers2000">Richter, M; A Iwata &amp; J Nyhuis et al. (2000), "Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo", <i>Physiological genomics</i> 2(3): 117-27, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11015590" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11015590">PMID 11015590</a></cite></li>
<li id="_note-KoeberlAlexander1997"><b><a href="#_ref-KoeberlAlexander1997_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFKoeberlAlexanderHalbertothers1997">Koeberl, DD; IE Alexander &amp; CL Halbert et al. (1997), "Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors", <i>Proceedings of the National Academy of Sciences of the United States of America</i> 94(4): 1426-31, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9037069" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9037069">PMID 9037069</a></cite></li>
<li id="_note-QinqMah1999"><b><a href="#_ref-QinqMah1999_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFQingMahHansenother1999">Qing, K; C Mah &amp; J Hansen et al. (1999), "Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2", <i>Nature medicine</i> 5(1): 71-7, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9883842" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9883842">PMID 9883842</a></cite></li>
<li id="_note-SummerfordSamulski1998"><b><a href="#_ref-SummerfordSamulski1998_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFSummerfordSamulski1998">Summerford, C &amp; RJ Samulski (1998), "Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions", <i>Journal of virology</i> 72(2): 1438-45, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9445046" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9445046">PMID 9445046</a></cite></li>
<li id="_note-SummerfordBartlett1999"><b><a href="#_ref-SummerfordBartlett1999_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFSummerfordBartlettSamulski1999">Summerford, C; JS Bartlett &amp; RJ Samulski (1999), "AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection", <i>Nature medicine</i> 5(1): 78-82, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9883843" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9883843">PMID 9883843</a></cite></li>
<li id="_note-QiuHanda2001"><b><a href="#_ref-QiuHanda2001_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFQiuHandaKirbyBrown2000">Qiu, J; A Handa &amp; M Kirby et al. (2000), "The interaction of heparin sulfate and adeno-associated virus 2", <i>Virology</i> 269(1): 137-47, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10725206" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10725206">PMID 10725206</a></cite></li>
<li id="_note-PajusolaGruchala2002"><b><a href="#_ref-PajusolaGruchala2002_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFPajusolaGruchalaJochother2002">Pajusola, K; M Gruchala &amp; H Joch et al. (2002), "Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells", <i>Journal of virology</i> 76(22): 11530-40, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12388714" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12388714">PMID 12388714</a></cite></li>
<li id="_note-Cnn2005"><b><a href="#_ref-Cnn2005_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFCNN.com2005">CNN.com (2005), <i><a href="http://www.cnn.com/2005/HEALTH/06/22/cancer.virus/index.html" class="external text" title="http://www.cnn.com/2005/HEALTH/06/22/cancer.virus/index.html" rel="nofollow">Common virus 'kills cancer'</a></i> [link accessed August 23, 2006]</cite></li>
<li id="_note-GaoAlvira2002"><b><a href="#_ref-GaoAlvira2002_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFGaoAlviraWangother2002">Gao, GP; MR Alvira &amp; L Wang et al. (2002),  <i>Proceedings of the National Academy of Sciences of the United States of America</i> 99(18): 11854-9, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12192090" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12192090">PMID 12192090</a></cite></li>
<li id="_note-HalbertAllen2001">^ <a href="#_ref-HalbertAllen2001_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-HalbertAllen2001_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" id="CITEREFHalbertAllenMiller2001">Halbert, CL; JM Allen &amp; AD Miller (2001), "Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors", <i>Journal of virology. (J Virol) Jul; ():</i> 75(14): 6615-24, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11413329" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11413329">PMID 11413329</a></cite></li>
<li id="_note-RabinowitzBowles2004">^ <a href="#_ref-RabinowitzBowles2004_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-RabinowitzBowles2004_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" id="CITEREFRabinowitzBowlesFaustother2004">Rabinowitz, JE; DE Bowles &amp; SM Faust et al. (2004), "Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups", <i>Journal of virology</i> 78(9): 4421-32, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15078923" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15078923">PMID 15078923</a></cite></li>
<li id="_note-ChenKapturczak2005"><b><a href="#_ref-ChenKapturczak2005_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFChenKapturczakLoilerothers2005">Chen, S; M Kapturczak &amp; SA Loiler et al. (2005), "Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors", <i>Human gene therapy</i> 16(2): 235-47, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15761263" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15761263">PMID 15761263</a></cite></li>
<li id="_note-KaludovBrown2001"><b><a href="#_ref-KaludovBrown2001_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFKaludovBrownWaltersothers2001">Kaludov, N; KE Brown &amp; RW Walters et al. (2001), "Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity", <i>Journal of virology</i> 75(15): 6884-93, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11435568" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11435568">PMID 11435568</a></cite></li>
<li id="_note-DiPasqualeDavidson2003"><b><a href="#_ref-DiPasqualeDavidson2003_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFDi_PasqualeDavidsonSteinothers">Di Pasquale, G; BL Davidson &amp; CS Stein et al., "Identification of PDGFR as a receptor for AAV-5 transduction", <i>Nature medicine</i> 9(10): 1306-12, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14502277" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14502277">PMID 14502277</a></cite></li>
<li id="_note-RohrKronenwett2002"><b><a href="#_ref-RohrKronenwett2002_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFRohrKronenwettGrimmothers2002">Rohr, UP; R Kronenwett &amp; D Grimm et al. (2002), "Primary human cells differ in their susceptibility to rAAV-2-mediated gene transfer and duration of reporter gene expression", <i>Journal of virological methods</i> 105(2): 265-75, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12270659" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12270659">PMID 12270659</a></cite></li>
<li id="_note-MatsushitaElliger1998">^ <a href="#_ref-MatsushitaElliger1998_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-MatsushitaElliger1998_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" id="CITEREFMatsushitaElligerElligerothers1998">Matsushita, T; S Elliger &amp; C Elliger et al. (1998), "Adeno-associated virus vectors can be efficiently produced without helper virus", <i>Gene therapy</i> 5(7): 938-45, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9813665" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9813665">PMID 9813665</a></cite></li>
<li id="_note-MyersLaughlin1980"><b><a href="#_ref-MyersLaughlin1980_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFMyersLaughlinJayother1980">Myers, MW; CA Laughlin &amp; FT Jay et al. (1980), "Adenovirus helper function for growth of adeno-associated virus: effect of temperature-sensitive mutations in adenovirus early gene region 2", <i>Journal of virology</i> 35(1): 65-75, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=6251278" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=6251278">PMID 6251278</a></cite></li>
<li id="_note-HandaCarter1979"><b><a href="#_ref-HandaCarter1979_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFHandaCarter1979">Handa, H &amp; BJ Carter (1979), "Adeno-associated virus DNA replication complexes in herpes simplex virus or adenovirus-infected cells", <i>The Journal of biological chemistry</i> 254(14): 6603-10, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=221504" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=221504">PMID 221504</a></cite></li>
<li id="_note-YalkinogluHeilbronn1988"><b><a href="#_ref-YalkinogluHeilbronn1988_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFYalkinogluHeilbronnB.C3.BCrkleother1988">Yalkinoglu, AO; R Heilbronn &amp; A BÃ¼rkle et al. (1988), "DNA amplification of adeno-associated virus as a response to cellular genotoxic stress", <i>Cancer research</i> 48(11): 3123-9, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2835153" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2835153">PMID 2835153</a></cite></li>
<li id="_note-YakobsonKoch1987"><b><a href="#_ref-YakobsonKoch1987_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFYakobsonKochWinocour1987">Yakobson, B; T Koch &amp; E Winocour (1987), "Replication of adeno-associated virus in synchronized cells without the addition of a helper virus", <i>Journal of virology</i> 61(4): 972-81, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3029431" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3029431">PMID 3029431</a></cite></li>
<li id="_note-YakobsonHrynko1989"><b><a href="#_ref-YakobsonHrynko1989_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFYakobsonHrynkoPeakWinocour1989">Yakobson, B; TA Hrynko &amp; MJ Peak et al. (1989), "Replication of adeno-associated virus in cells irradiated with UV light at 254 nm", <i>Journal of virology</i> 63(3): 1023-30, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2536816" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2536816">PMID 2536816</a></cite></li>
<li id="_note-DuanSharma1998"><b><a href="#_ref-DuanSharma1998_0" title="">^</a></b> <cite style="font-style:normal" id="CITEREFDuanSharmaYangothers1998">Duan, D; P Sharma &amp; J Yang et al. (1998), "Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue", <i>Journal of virology</i> 72(11): 8568-77, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9765395" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9765395">PMID 9765395</a></cite></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/d/e/Adeno-associated_virus.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/G/GeneTherapy2.html" class="external free" title="http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/G/GeneTherapy2.html" rel="nofollow">http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/G/GeneTherapy2.html</a></li>
</ul>

<!-- 
Pre-expand include size: 1027393 bytes
Post-expand include size: 203336 bytes
Template argument size: 117840 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/d/e/Adeno-associated_virus.html">http://en.wikipedia.org../../../a/d/e/Adeno-associated_virus.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_to_be_expanded_since_January_2007_bea1.html" title="Category:Articles to be expanded since January 2007">Articles to be expanded since January 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_to_be_expanded_930f.html" title="Category:All articles to be expanded">All articles to be expanded</a></span> | <span dir='ltr'><a href="../../../a/p/p/Category%7EApplied_genetics_6fa1.html" title="Category:Applied genetics">Applied genetics</a></span> | <span dir='ltr'><a href="../../../o/n/c/Category%7EOncology_7a32.html" title="Category:Oncology">Oncology</a></span> | <span dir='ltr'><a href="../../../v/i/r/Category%7EViruses_a41a.html" title="Category:Viruses">Viruses</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/d/e/Adeno-associated_virus.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/d/e/Talk%7EAdeno-associated_virus_d556.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Adeno-associated_virus">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/d/e/Adeno-assoziierte_Viren_1ebb.html">Deutsch</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 18:03, 5 April 2007 by Wikipedia user ThinkerThoughts. Based on work by Wikipedia user(s) <a href="../../../i/n/t/User%7EIntgr_3172.html" title="User:Intgr">Intgr</a>, <a href="../../../d/o/k/User%7EDoktorDec_362f.html" title="User:DoktorDec">DoktorDec</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../m/e/i/User%7EMeiquer_c21c.html" title="User:Meiquer">Meiquer</a>, <a href="../../../t/h/a/User%7EThaurisil_2734.html" title="User:Thaurisil">Thaurisil</a>, <a href="../../../m/i/k/User%7EMike_Dillon_10d0.html" title="User:Mike Dillon">Mike Dillon</a>, <a href="../../../j/e/n/User%7EJenLouise_6ad3.html" title="User:JenLouise">JenLouise</a>, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../n/i/n/User%7ENina_Gerlach_3180.html" title="User:Nina Gerlach">Nina Gerlach</a>, <a href="../../../r/i/a/User%7ERiana_7579.html" title="User:Riana">Riana</a>, <a href="../../../s/t/e/User%7EStevenfruitsmaak_e31a.html" title="User:Stevenfruitsmaak">Stevenfruitsmaak</a>, <a href="../../../r/a/i/User%7ERainbowCrane_2800.html" title="User:RainbowCrane">RainbowCrane</a>, <a href="../../../y/o/m/User%7EYomangani_bb58.html" title="User:Yomangani">Yomangani</a>, <a href="../../../a/l/m/User%7EAlmeo_3520.html" title="User:Almeo">Almeo</a>, <a href="../../../m/u/s/User%7EMushin_04d4.html" title="User:Mushin">Mushin</a>, <a href="../../../n/e/k/User%7ENekoDaemon_8f79.html" title="User:NekoDaemon">NekoDaemon</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../z/e/w/User%7EZeWrestler_d815.html" title="User:ZeWrestler">ZeWrestler</a>, <a href="../../../n/j/m/User%7ENJM_fc56.html" title="User:NJM">NJM</a>, <a href="../../../s/i/m/User%7ESimonP_1010.html" title="User:SimonP">SimonP</a> and Vind r and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
